Michael Slimack, DO
Adult Reconstructive Orthopaedic Surgery · Kenosha, WINPI 1356558464
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 5 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Medacta USA, Inc. accounts for 69.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $117 and has fallen 86.1% since, to $16 in 2025.
Across 5 payments — averaging $33.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medacta USA, Inc.$117
- Organogenesis Inc.$21
- Solventum Corporation$16
- Amgen$15
What the payments were for
- Food & beverage$169100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medacta USA, Inc. | 2 | $117 |
| Organogenesis Inc. | 1 | $21 |
| Solventum Corporation | 1 | $16 |
| Amgen | 1 | $15 |
How this compares
Too few adult reconstructive orthopaedic surgery providers in Wisconsinto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 52 | $3,040 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 182 | $2,147 |
| Mupirocin | 204 | $1,471 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 36 | $416 |
| Methylprednisolone | 42 | $312 |
| Omeprazole | 44 | $265 |
| Amoxicillin | 252 | $258 |
| Cephalexin | 69 | $184 |
| Meloxicam | 60 | $163 |
| Cefadroxil | 17 | $107 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 12 | $105 |
| Clindamycin Hcl | 47 | $90 |
| Tramadol Hcl | 16 | $66 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Kenosha
- William LutesKenosha$1M
- Rafael Walker SantiagoGrafton$29K
- Gordon RoedelGreen Bay$21K
- Oliver ScottingMenomonee Falls$14K
- Edward Nelsen FreundMilwaukee$13K
- Frank RodgersMadison$6K
- Charles GreenSheboygan$3K
- Rusty BrandEau Claire$845
- Kevin WeidmanMilwaukee$192
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.